相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combination of serum and CSF neurofilament-light and neuroinflammatory biomarkers to evaluate ALS
Alexandre Brodovitch et al.
SCIENTIFIC REPORTS (2021)
High TG/HDL ratio suggests a higher risk of metabolic syndrome among an elderly Chinese population: a cross-sectional study
Guqiao Nie et al.
BMJ OPEN (2021)
The Role of High Triglycerides Level in Predicting Cognitive Impairment: A Review of Current Evidence
AlMa Mihaela Dimache et al.
NUTRIENTS (2021)
Temporal Ordering of Inflammatory Analytes sTNFR2 and sTREM2 in Relation to Alzheimer's Disease Biomarkers and Clinical Outcomes
Jagan A. Pillai et al.
FRONTIERS IN AGING NEUROSCIENCE (2021)
Apolipoprotein A1, the neglected relative of Apolipoprotein E and its potential role in Alzheimer's disease
Kristina Endres
NEURAL REGENERATION RESEARCH (2021)
Elevated serum TC and LDL-C levels in Alzheimer's disease and mild cognitive impairment: A meta-analysis study
Yang Liu et al.
BRAIN RESEARCH (2020)
Major Lipids, Apolipoproteins, and Alterations of Gut Microbiota
Kyung Eun Yun et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Serum triglycerides in Alzheimer disease: Relation to neuroimaging and CSF biomarkers
Megan M. Bernath et al.
NEUROLOGY (2020)
Method comparison study of the Elecsys® β-Amyloid (1-42) CSF assay versus comparator assays and LC-MS/MS
Leslie M. Shaw et al.
CLINICAL BIOCHEMISTRY (2019)
Key inflammatory pathway activations in the MCI stage of Alzheimer's disease
Jagan A. Pillai et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer's disease
Michael Ewers et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Association of ideal cardiovascular health at age 50 with incidence of dementia: 25 year follow-up of Whitehall II cohort study
Séverine Sabia et al.
BMJ-British Medical Journal (2019)
Diabetes mellitus and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 144 prospective studies
Mei Xue et al.
AGEING RESEARCH REVIEWS (2019)
Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction
Daniel A. Nation et al.
NATURE MEDICINE (2019)
Metabolic Syndrome, Mild Cognitive Impairment, and Dementia: A Meta-Analysis of Longitudinal Studies
Anna Rita Atti et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2019)
Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Melanie D. Sweeney et al.
NATURE REVIEWS NEUROLOGY (2018)
Association between insulin resistance and the development of cardiovascular disease
Valeska Ormazabal et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly
Rosalinde E. R. Slot et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
KEGG as a reference resource for gene and protein annotation
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2016)
Apolipoproteins and HDL cholesterol do not associate with the risk of future dementia and Alzheimer's disease: the National Finnish population study (FINRISK)
Juho Tynkkynen et al.
AGE (2016)
Association Between Serum Triglycerides and Cerebral Amyloidosis in Cognitively Normal Elderly
Hyo Jung Choi et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2016)
Insulin Resistance Predicts Medial Temporal Hypermetabolism in Mild Cognitive Impairment Conversion to Alzheimer Disease
Auriel A. Willette et al.
DIABETES (2015)
Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study
Soren D. Ostergaard et al.
PLOS MEDICINE (2015)
Identification of Cardiometabolic Risk: Visceral Adiposity Index Versus Triglyceride/HDL Cholesterol Ratio
Martin R. Salazar et al.
AMERICAN JOURNAL OF MEDICINE (2014)
HDL and cholesterol handling in the brain
Cecilia Vitali et al.
CARDIOVASCULAR RESEARCH (2014)
HDL and cognition in neurodegenerative disorders
David A. Hottman et al.
NEUROBIOLOGY OF DISEASE (2014)
Associations Between Serum Cholesterol Levels and Cerebral Amyloidosis
Bruce Reed et al.
JAMA NEUROLOGY (2014)
Very Old Adults with Better Memory Function have Higher Low-Density Lipoprotein Cholesterol Levels and Lower Triglyceride to High-Density Lipoprotein Cholesterol Ratios: KOCOA Project
Yuriko Katsumata et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
The LXR agonist GW3965 increases apoA-I protein levels in the central nervous system independent of ABCA1
Sophie Stukas et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2012)
Plasma Apolipoprotein Levels Are Associated with Cognitive Status and Decline in a Community Cohort of Older Individuals
Fei Song et al.
PLOS ONE (2012)
Apolipoprotein A-I Deficiency Increases Cerebral Amyloid Angiopathy and Cognitive Deficits in APP/PS1ΔE9 Mice
Iliya Lefterov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Overexpression of Human Apolipoprotein A-I Preserves Cognitive Function and Attenuates Neuroinflammation and Cerebral Amyloid Angiopathy in a Mouse Model of Alzheimer Disease
Terry L. Lewis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Differential Roles for Endothelial ICAM-1, ICAM-2, and VCAM-1 in Shear-Resistant T Cell Arrest, Polarization, and Directed Crawling on Blood-Brain Barrier Endothelium
Oliver Steiner et al.
JOURNAL OF IMMUNOLOGY (2010)
Serum Lipid Levels and Cognitive Change in Late Life
Chandra A. Reynolds et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2010)
A comprehensive definition for metabolic syndrome
Paul L. Huang
DISEASE MODELS & MECHANISMS (2009)
Does the association of the triglyceride to high-density lipoprotein cholesterol ratio with fasting serum insulin differ by race/ethnicity?
Chaoyang Li et al.
CARDIOVASCULAR DIABETOLOGY (2008)
An Apolipoprotein A-1 gene promoter polymorphism associated with cognitive decline, but not with Alzheimer's disease
Nicole Helbecque et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2008)
Time course of VCAM-1 and ICAM-1 in CSF in patients with basal ganglia haemorrhage
J. Kraus et al.
ACTA NEUROLOGICA SCANDINAVICA (2007)
The relation between apolipoprotein A-I and dementia - The Honolulu-Asia aging study
Jane S. Saczynski et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Apolipoprotein A1 is a stronger prognostic marker than are HDL and LDL cholesterol for cardiovascular disease and mortality in elderly men
Gosta Florvall et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2006)
Apolipoproteins as predictors of ischaemic stroke in patients with a previous transient ischaemic attack
M. Bhatia et al.
CEREBROVASCULAR DISEASES (2006)
Mixed dementia - Emerging. concepts and therapeutic implications
KM Langa et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Use of metabolic markers to identify overweight individuals who are insulin resistant
T McLaughlin et al.
ANNALS OF INTERNAL MEDICINE (2003)
Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease
A Merched et al.
NEUROBIOLOGY OF AGING (2000)
分享论文
